Ozempic, Wegovy, and Rybelsus are semaglutide-containing drugs from Novo Nordisk. Starting in 2024, there have been reports of non-arteritic anterior ischemic optic neuropathy, or NAION, associated with these semaglutide-containing drugs. And there is new medical evidence in 2026 regarding NAION … More
Main Navigation Menu
➤ About the Law Offices of Thomas J. Lamb
PRACTICE AREAS
➤ Asbestos and Mesothelioma Claims
➤ Benzene Cancer and Disease Claims
➤ Pharmaceutical Drug Injury Lawsuits
➤ Breast Implants Lymphoma Cancer Lawsuits
➤ Free Case Evaluation by Lawyer Tom Lamb
INFORMATION
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Our "Recent Articles" Archives
To save time, you can use our Quick Contact Form to tell us about your possible case.
Recent Articles
Rybelsus Lawsuits for Pancreatitis Death Cases
We are investigating Rybelsus lawsuits, with a focus on cases of hemorrhagic pancreatitis or necrotizing pancreatitis involving death. Those Rybeslus pancreatitis death cases would be filed against the responsible pharmaceutical company, Novo Nordisk. The best Rybelsus lawsuits would be for … More
Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study
Background: Pembrolizumab (anti-PD-1 antibody) plus lenvatinib (multityrosine kinase inhibitor) showed high clinical activity in PEMMELA cohort 1 in patients with pleural mesothelioma pre-treated with platinum-based chemotherapy. This study (cohort 2) aimed to investigate the clinical activity of … More
Depo-Provera Legal Compensation Cases After Meningioma Warning Added to Drug Label in 2025
Question: Can Depo-Provera legal compensation cases still be filed after a meningioma warning was added in December 2025 to the Depo-Provera drug label? Short Answer: Yes, new Depo-Provera lawsuits can be filed if you received a Depo-Provera injection before December 2025, and were diagnosed with … More
Semaglutide Deep Vein Thrombosis Case Information: 2026 Medical Journal Article
A 2026 medical journal article, which presented some semaglutide deep vein thrombosis case information, is of interest to us because Ozempic, Wegovy, and Rybelsus — three relatively new semaglutide-containing drugs — have been associated with a significantly increased risk of blood clots. We have … More
Pericardial Mesothelioma: Diagnostic and Therapeutic Management, a Population-Based Study in Italy
Pericardial mesothelioma (PM) is an extremely rare tumour for which only case reports, small case series, and case reviews have been published. This is a large population-based study on PM in Italy using data from the Italian National Mesothelioma Registry (Registro Nazionale Mesoteliomi, ReNaM). … More